{{Rsnum
|rsid=1444754
|Gene=KALRN
|Chromosome=3
|position=124219370
|Orientation=plus
|GMAF=0.4835
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=KALRN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 17.7 | 47.8 | 34.5
| HCB | 30.7 | 51.1 | 18.2
| JPT | 35.4 | 45.1 | 19.5
| YRI | 33.3 | 42.2 | 24.5
| ASW | 31.6 | 52.6 | 15.8
| CHB | 30.7 | 51.1 | 18.2
| CHD | 36.1 | 42.6 | 21.3
| GIH | 29.7 | 38.6 | 31.7
| LWK | 40.9 | 45.5 | 13.6
| MEX | 20.7 | 50.0 | 29.3
| MKK | 34.6 | 50.6 | 14.7
| TSI | 16.7 | 64.7 | 18.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19706030
|Title=Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13-21 and Potential Effect Modification by Smoking
|OA=1
}}

{{PMID Auto
|PMID=17357071
|Title=Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}